LSL Pharma Group IncOTC Pink - Current Information:LPGIFView on Canadian Exchange
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range---
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Yesterday
Press Release: LSL PHARMA GROUP ANNOUNCES STRONG FISCAL Q3-24 RESULTS AND $2.4 MILLION DEBT FINANCINGS TO SUPPORT ITS GROWTH INITIATIVES, from 7:00AM ET on Monday Nov 25, 2024 by Dow Jones
7:00AM ET on Monday Nov 25, 2024 by Dow JonesLSL PHARMA GROUP ANNOUNCES STRONG FISCAL Q3-24 RESULTS AND $2.4 MILLION DEBT FINANCINGS TO SUPPORT ITS GROWTH INITIATIVES, from 7:00AM ET on Monday Nov 25, 2024 by Dow Jones
7:00AM ET on Monday Nov 25, 2024 by Dow Jones
Nov 6, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
LSL Pharma Group Inc | 49.7M | --- | --- |
Company Information
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company. The Company is specialized in the development, manufacturing and commercialization of sterile ophthalmic pharmaceuticals, as well as natural health products in solid dosage forms. It specializes in the manufacturing and marketing of natural health products (NHPs). The Company manufactures a range of NHPs in liquid, powder and capsule form, sold under its own brand or under private labels. Its manufacturing activities include blistering, encapsulation, sachet and jar filling. The Company's subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Groupe Immobilier LSL inc.
Contact Information
- Headquarters
- 540, rue d'Avaugour, Office 1800BOUCHERVILLE, QC, Canada J4B 0G6
- Phone
- 450-681-7744
- Fax
- 450-681-8400
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $49.7M |
|---|---|
Revenue (TTM) | $14.3M |
Shares Outstanding | 115.5M |
LSL Pharma Group Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.02 |
Book Value | $0.10 |
P/E Ratio | --- |
Price/Sales (TTM) | 3.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
